Covered recipient · General Payments record
MAX FELDMAN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2020–2024
$1,234.79
- Reported across 65 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $310.35 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $158.69 | 8 |
| PFIZER INC. | $25.20 | 1 |
| Dynavax Technologies Corporation | $23.92 | 1 |
| GlaxoSmithKline, LLC. | $22.72 | 1 |
| Merck Sharp & Dohme Corporation | $21.51 | 1 |
| Corium, Inc. | $20.86 | 1 |
| Acerta Pharma LLC | $19.40 | 1 |
| Amgen Inc. | $18.05 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $18.05 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117249827 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.40 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104261523 | CMS |
| Corium, LLC | $20.86 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100180174 | CMS |
| Dynavax Technologies Corporation | $23.92 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082147641 | CMS |
| GlaxoSmithKline, LLC. | $22.72 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116341420 | CMS |
| Merck Sharp & Dohme LLC | $21.51 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141634265 | CMS |
| Novo Nordisk Inc | $8.16 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097015088 | CMS |
| Novo Nordisk Inc | $17.30 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096694499 | CMS |
| Novo Nordisk Inc | $26.25 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097313006 | CMS |
| Novo Nordisk Inc | $19.41 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097060399 | CMS |
| Novo Nordisk Inc | $23.02 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096919602 | CMS |
| Novo Nordisk Inc | $18.44 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096890866 | CMS |
| Novo Nordisk Inc | $18.93 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097563516 | CMS |
| Novo Nordisk Inc | $27.18 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096938923 | CMS |
| PFIZER INC. | $25.20 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131364744 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.